A detailed history of Panagora Asset Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Panagora Asset Management Inc holds 5,030 shares of UTHR stock, worth $1.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,030
Previous 5,729 12.2%
Holding current value
$1.88 Million
Previous $1.82 Million 1.21%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $217,416 - $254,121
-699 Reduced 12.2%
5,030 $1.8 Million
Q2 2024

Jul 29, 2024

SELL
$228.26 - $319.04 $313,172 - $437,722
-1,372 Reduced 19.32%
5,729 $1.82 Million
Q1 2024

May 07, 2024

BUY
$210.76 - $249.51 $89,783 - $106,291
426 Added 6.38%
7,101 $1.63 Million
Q4 2023

Feb 08, 2024

BUY
$214.88 - $256.94 $1.17 Million - $1.39 Million
5,429 Added 435.71%
6,675 $1.47 Million
Q3 2023

Oct 31, 2023

SELL
$211.82 - $248.24 $1,059 - $1,241
-5 Reduced 0.4%
1,246 $281,000
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $29,957 - $34,016
146 Added 13.21%
1,251 $276,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $5,560 - $7,571
27 Added 2.5%
1,105 $307,000
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $5.02 Million - $6.02 Million
-24,675 Reduced 95.81%
1,078 $226,000
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $3.28 Million - $4.53 Million
18,783 Added 269.48%
25,753 $6.07 Million
Q1 2022

May 12, 2022

BUY
$166.16 - $213.96 $996 - $1,283
6 Added 0.09%
6,970 $1.25 Million
Q4 2021

Feb 10, 2022

SELL
$184.32 - $216.08 $28.5 Million - $33.4 Million
-154,777 Reduced 95.69%
6,964 $1.51 Million
Q3 2021

Nov 10, 2021

SELL
$179.86 - $214.88 $669,438 - $799,783
-3,722 Reduced 2.25%
161,741 $29.9 Million
Q2 2021

Aug 11, 2021

SELL
$170.47 - $211.93 $2.99 Million - $3.72 Million
-17,536 Reduced 9.58%
165,463 $29.7 Million
Q1 2021

May 12, 2021

SELL
$153.94 - $174.85 $2.99 Million - $3.39 Million
-19,415 Reduced 9.59%
182,999 $30.6 Million
Q4 2020

Feb 10, 2021

BUY
$101.87 - $151.79 $16.2 Million - $24.1 Million
158,861 Added 364.75%
202,414 $30.7 Million
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $4.22 Million - $5.12 Million
42,263 Added 3276.2%
43,553 $4.4 Million
Q2 2020

Aug 12, 2020

SELL
$92.74 - $125.82 $556 - $754
-6 Reduced 0.46%
1,290 $156,000
Q1 2020

May 14, 2020

BUY
$79.39 - $115.35 $714 - $1,038
9 Added 0.7%
1,296 $123,000
Q4 2019

Feb 12, 2020

BUY
$78.31 - $95.34 $17,228 - $20,974
220 Added 20.62%
1,287 $113,000
Q2 2019

Aug 09, 2019

SELL
$76.06 - $120.81 $460,999 - $732,229
-6,061 Reduced 85.03%
1,067 $83,000
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $272,482 - $322,554
2,543 Added 55.46%
7,128 $837,000
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $405 - $514
-4 Reduced 0.09%
4,585 $499,000
Q3 2018

Nov 13, 2018

BUY
$113.81 - $129.46 $910 - $1,035
8 Added 0.17%
4,589 $587,000
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $225,238 - $263,476
2,227 Added 94.6%
4,581 $518,000
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $183,436 - $259,969
-1,711 Reduced 42.09%
2,354 $264,000
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $5,454 - $6,958
46 Added 1.14%
4,065 $601,000
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $460,577 - $549,839
4,019
4,019 $471,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.